Tiziana Life Sciences wins FDA approval to add patients to M

Tiziana Life Sciences Ltd (NASDAQ:TLSA) announced that it has been approved by the US Food and Drug Administration to expand patient enrollment in its...

Related Keywords

Gabriele Cerrone , Tanuja Chitnis , Tiziana Life Sciences Ltd , Drug Administration , Access Program , Secondary Progressive Multiple Sclerosis , Expanded Access , Expanded Access Program ,